Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Cutan Med Surg. 2012 Jun;31(2):133-9. doi: 10.1016/j.sder.2012.03.001.

New horizons in treating disorders of hyperpigmentation in skin of color.

Author information

  • 1Department of Dermatology, Howard University College of Medicine, Washington, DC 20060, USA.

Abstract

Pigmentary abnormalities are among the most common reasons why patients with skin of color visit a dermatologist. Hydroquinone has been a cornerstone for the treatment of hyperpigmentation; however, concerns regarding adverse effects have prompted a search for alternative agents. Some promising topical treatments include soy, licorice, rucinol, mulberry, niacinamide, ellagic acid, resveratrol, and dioic acid. Oral agents, primarily used for the prevention of postprocedural hyperpigmentation, include procyanidins, tranexamic acid, and Polypodium leucotomos. Advances in Q-switched lasers, intense pulse light, fractional photothermolysis, and the advent of tretinoin peeling add to the clinician's armamentarium for treating hyperpigmentation.

Copyright © 2012 Elsevier Inc. All rights reserved.

PMID:
22640434
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Frontline Medical Communications Inc
    Loading ...
    Write to the Help Desk